SMO and hepatocellular carcinoma: Kaplan-Meier survival analysis showed that HCC patients with high expression of SMO exhibited shorter overall survival (Figure S8D), and patients with high expression of both PCSK9 and SMO demonstrated the worst overall survival (Figure 5F).